JBS stock forecast, quote, news & analysis

Key Takeaways

• JBS (JBS) shares are trading near the lower end of a 52-week range of $11.49 to $18.65, holding in the low-$12 area.
• The stock has moved only modestly over the past month, rising roughly 6% from about $11.96 in mid-September to near $12.70.
• JBS remains the world's largest animal-protein processor, with trailing 12-month revenue of roughly $91 billion.
• Valuation appears moderate versus peers, with a forward price-to-earnings ratio near 12 and an EV/EBITDA multiple near 6.5.
• The next confirmed earnings report is scheduled for November 9, 2026, a key event for investor sentiment.
• Analyst consensus remains broadly positive, with an average price target near $18.84, though the shares have lagged that level.

Current Market Snapshot

JBS N.V. shares have been consolidating in a narrow band in recent sessions, trading near $12.70 as of late October 2026. That places the stock firmly in the lower portion of its 52-week range, which stretches from $11.49 to $18.65. The share price also sits below its 200-day moving average of roughly $14.17, a technical signal that the stock remains in a longer-term downtrend even as short-term selling pressure has eased.

The relatively calm 30-day performance stands in contrast to the stock's broader slide from its post-listing highs. JBS began trading on the New York Stock Exchange in June 2025 under the ticker JBS, completing a long-delayed dual listing that expanded its access to U.S. capital markets. Since then, the shares have faced pressure from softer earnings momentum and broader volatility in the global protein sector.

JBS (JBS) Business Overview and Competitive Position

JBS is the world's largest animal-protein company, processing and distributing beef, pork, poultry, lamb, and fish to retail, foodservice, and industrial customers across more than 100 countries. Its portfolio spans several reportable segments, including Beef North America, Brazil, Seara, Pork USA, Pilgrim's Pride, and Australia, alongside leather, collagen, and prepared-foods businesses. The company is the majority owner of U.S. poultry producer Pilgrim's Pride.

The company's scale is a defining competitive advantage. It operates hundreds of facilities and benefits from geographic and protein diversification that helps offset swings in any single commodity or regional market. Investors follow JBS for its exposure to global protein demand, its cost-advantaged production base in Brazil and the United States, and its ability to generate cash across the protein cycle. At the same time, the stock carries an elevated debt load and a governance structure in which the founding Batista family, through J&F Investimentos, retains roughly half of voting control.

Recent Developments Driving JBS

Over the past month, JBS has drawn attention for its valuation rather than any single blockbuster catalyst. The stock's forward P/E near 12 and EV/EBITDA near 6.5 sit at the lower end of the food and protein peer group, and the shares carry a dividend yield in the high single digits, though special distributions can push the trailing figure higher. This income profile has kept JBS on the radar of value- and income-oriented investors.

On the fundamental side, earnings momentum has been mixed. Recent quarters showed a year-over-year decline in earnings per share, reflecting pressure from cattle and feed costs, currency movements, and softer margins in some protein categories. The company also continues to pursue bolt-on acquisitions, including recent transactions in the Middle East and Latin America, which expand its footprint but also add to an already sizable debt position. Institutional ownership remains meaningful, and short interest has been elevated relative to the float, contributing to periodic volatility.

Trending AI Robots

For traders looking to complement their own analysis, Tickeron's Trending AI Robots page offers a curated view of automated trading strategies. Tickeron provides hundreds of AI trading bots that monitor thousands of tickers, but only the top-performing and most relevant bots are featured in this section, helping users cut through the noise. The bots vary widely in strategy, timeframe, and performance metrics, ranging from short-term technical setups to longer-horizon trend-following approaches. Exploring the page can give investors a data-driven perspective on how algorithmic systems are positioning across the market, including in the consumer staples and protein sectors.

2026 Outlook and What Investors Should Watch

Looking ahead, several factors will shape JBS's trajectory through the remainder of 2026 and into 2027. The November 9, 2026 earnings report will be a near-term focal point, with investors scrutinizing volume trends, protein margins, and management's guidance against a backdrop of elevated feed and cattle costs. Macroeconomic conditions, including inflation in food inputs and currency fluctuations between the Brazilian real and U.S. dollar, also remain central to profitability.

Competitive dynamics matter as well. Rivals such as Tyson Foods, Smithfield Foods, and BRF compete across overlapping protein categories, while demand trends for premium and value-priced proteins continue to evolve. Investors will also monitor the company's debt reduction progress, governance and ESG scrutiny, and whether the valuation gap relative to peers begins to narrow. The average analyst price target near $18.84 implies meaningful upside from current levels, but achieving that would likely require a sustained recovery in earnings momentum and margin expansion.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations